IMR Press / EJGO / Volume 32 / Issue 2 / pii/1630979936579-636641898

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with S.O.G.

Case Report
Peptide YY producing strumal carcinoid tumor of the ovary
Show Less
1 Departments of Obstetrics and Gynecology, 2Pathology, and 3Institute of Endocrine-Related Cancer, Matsunami General Hospital, Gifu (Japan)
Eur. J. Gynaecol. Oncol. 2011, 32(2), 201–202;
Published: 10 April 2011

Background: Primary ovarian carcinoid tumor is uncommon and represents less than 0.1% of ovarian malignancies. The strumal carcinoid may be complicated by carcinoid syndrome induced by peptide YY (PYY). Case report:We describe a 45-year-old woman with a bilateral ovarian tumor diagnosed through periodical gynecological examination. She presented with severe constipation. Right ovarian cyst laparoscopically resected was diagnosed as a strumal carcinoid tumor; the left one was mature cystic teratoma. No metastatic findings were seen macroscopically on the ovarian surface and pelvic peritoneum. Constipation was drastically improved by resecting the tumor. The carcinoid tumor cells were positive for tumor-producing PYY by mRNA analysis. Conclusion: It is important to be aware of this entity in the pathological diagnosis of ovarian tumors, in the presence of any clinical indicator of carcinoid tumor/syndrome, as it carries a markedly better prognosis and clinical outcome in comparison with most other malignant ovarian tumors.
Ovarian strumal carcinoid
Carcinoid syndrome
Back to top